Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 134

1.

Beta protein 1 homeoprotein induces cell growth and estrogen-independent tumorigenesis by binding to the estrogen receptor in breast cancer.

Fu SW, Kirolikar SP, Ginsburg E, Tan X, Schwartz A, Simmens SJ, Man YG, Pinzone JJ, Teal C, Awate S, Vonderhaar BK, Berg PE.

Oncotarget. 2016 Aug 16;7(33):53204-53216. doi: 10.18632/oncotarget.10633.

2.

Prolactin receptor expression and breast cancer: relationships with tumor characteristics among pre- and post-menopausal women in a population-based case-control study from Poland.

Faupel-Badger JM, Duggan MA, Sherman ME, Garcia-Closas M, Yang XR, Lissowska J, Brinton LA, Peplonska B, Vonderhaar BK, Figueroa JD.

Horm Cancer. 2014 Feb;5(1):42-50. doi: 10.1007/s12672-013-0165-7.

3.

Characterization of Δ7/11, a functional prolactin-binding protein.

Fleming JM, Ginsburg E, McAndrew CW, Heger CD, Cheston L, Rodriguez-Canales J, Vonderhaar BK, Goldsmith P.

J Mol Endocrinol. 2012 Dec 31;50(1):79-90. doi: 10.1530/JME-12-0201.

4.

Paracrine interactions between primary human macrophages and human fibroblasts enhance murine mammary gland humanization in vivo.

Fleming JM, Miller TC, Kidacki M, Ginsburg E, Stuelten CH, Stewart DA, Troester MA, Vonderhaar BK.

Breast Cancer Res. 2012 Jun 25;14(3):R97.

5.

Hornerin, an S100 family protein, is functional in breast cells and aberrantly expressed in breast cancer.

Fleming JM, Ginsburg E, Oliver SD, Goldsmith P, Vonderhaar BK.

BMC Cancer. 2012 Jun 22;12:266. doi: 10.1186/1471-2407-12-266.

6.

Progesterone receptor activates Msx2 expression by downregulating TNAP/Akp2 and activating the Bmp pathway in EpH4 mouse mammary epithelial cells.

Fleming JM, Ginsburg E, Goldhar AS, Plant J, Vonderhaar BK.

PLoS One. 2012;7(3):e34058. doi: 10.1371/journal.pone.0034058.

7.

Expression of Notch receptors, ligands, and target genes during development of the mouse mammary gland.

Raafat A, Goldhar AS, Klauzinska M, Xu K, Amirjazil I, McCurdy D, Lashin K, Salomon D, Vonderhaar BK, Egan S, Callahan R.

J Cell Physiol. 2011 Jul;226(7):1940-52. doi: 10.1002/jcp.22526.

8.

Genetic variation in PRL and PRLR, and relationships with serum prolactin levels and breast cancer risk: results from a population-based case-control study in Poland.

Nyante SJ, Faupel-Badger JM, Sherman ME, Pfeiffer RM, Gaudet MM, Falk RT, Andaya AA, Lissowska J, Brinton LA, Peplonska B, Vonderhaar BK, Chanock S, Garcia-Closas M, Figueroa JD.

Breast Cancer Res. 2011 Apr 6;13(2):R42. doi: 10.1186/bcr2864.

9.

Progesterone induces expression of the prolactin receptor gene through cooperative action of Sp1 and C/EBP.

Goldhar AS, Duan R, Ginsburg E, Vonderhaar BK.

Mol Cell Endocrinol. 2011 Mar 30;335(2):148-57. doi: 10.1016/j.mce.2011.01.004.

10.

Characterization of ductal and lobular breast carcinomas using novel prolactin receptor isoform specific antibodies.

Ginsburg E, Alexander S, Lieber S, Tarplin S, Jenkins L, Pang L, Heger CD, Goldsmith P, Vonderhaar BK.

BMC Cancer. 2010 Dec 13;10:678. doi: 10.1186/1471-2407-10-678.

11.

16 kDa prolactin reduces angiogenesis, but not growth of human breast cancer tumors in vivo.

Faupel-Badger JM, Ginsburg E, Fleming JM, Susser L, Doucet T, Vonderhaar BK.

Horm Cancer. 2010 Apr;1(2):71-9. doi: 10.1007/s12672-010-0012-z.

12.

Transforming acidic coiled-coil protein-3 (Tacc3) acts as a negative regulator of Notch signaling through binding to CDC10/Ankyrin repeats.

Bargo S, Raafat A, McCurdy D, Amirjazil I, Shu Y, Traicoff J, Plant J, Vonderhaar BK, Callahan R.

Biochem Biophys Res Commun. 2010 Oct 1;400(4):606-12. doi: 10.1016/j.bbrc.2010.08.111.

13.

Prolactin serum levels and breast cancer: relationships with risk factors and tumour characteristics among pre- and postmenopausal women in a population-based case-control study from Poland.

Faupel-Badger JM, Sherman ME, Garcia-Closas M, Gaudet MM, Falk RT, Andaya A, Pfeiffer RM, Yang XR, Lissowska J, Brinton LA, Peplonska B, Vonderhaar BK, Figueroa JD.

Br J Cancer. 2010 Sep 28;103(7):1097-102. doi: 10.1038/sj.bjc.6605844.

14.

Local regulation of human breast xenograft models.

Fleming JM, Miller TC, Meyer MJ, Ginsburg E, Vonderhaar BK.

J Cell Physiol. 2010 Sep;224(3):795-806. doi: 10.1002/jcp.22190.

15.

Cripto-1 is a cell surface marker for a tumorigenic, undifferentiated subpopulation in human embryonal carcinoma cells.

Watanabe K, Meyer MJ, Strizzi L, Lee JM, Gonzales M, Bianco C, Nagaoka T, Farid SS, Margaryan N, Hendrix MJ, Vonderhaar BK, Salomon DS.

Stem Cells. 2010 Aug;28(8):1303-14. doi: 10.1002/stem.463.

16.

The normal breast microenvironment of premenopausal women differentially influences the behavior of breast cancer cells in vitro and in vivo.

Fleming JM, Miller TC, Quinones M, Xiao Z, Xu X, Meyer MJ, Ginsburg E, Veenstra TD, Vonderhaar BK.

BMC Med. 2010 May 21;8:27. doi: 10.1186/1741-7015-8-27.

17.

CD44posCD49fhiCD133/2hi defines xenograft-initiating cells in estrogen receptor-negative breast cancer.

Meyer MJ, Fleming JM, Lin AF, Hussnain SA, Ginsburg E, Vonderhaar BK.

Cancer Res. 2010 Jun 1;70(11):4624-33. doi: 10.1158/0008-5472.CAN-09-3619.

18.

Dynamic regulation of CD24 and the invasive, CD44posCD24neg phenotype in breast cancer cell lines.

Meyer MJ, Fleming JM, Ali MA, Pesesky MW, Ginsburg E, Vonderhaar BK.

Breast Cancer Res. 2009;11(6):R82. doi: 10.1186/bcr2449.

19.

Identification of a regulatory loop for the synthesis of neurosteroids: a steroidogenic acute regulatory protein-dependent mechanism involving hypothalamic-pituitary-gonadal axis receptors.

Meethal SV, Liu T, Chan HW, Ginsburg E, Wilson AC, Gray DN, Bowen RL, Vonderhaar BK, Atwood CS.

J Neurochem. 2009 Aug;110(3):1014-27. doi: 10.1111/j.1471-4159.2009.06192.x.

20.

Msx2 induces epithelial-mesenchymal transition in mouse mammary epithelial cells through upregulation of Cripto-1.

di Bari MG, Ginsburg E, Plant J, Strizzi L, Salomon DS, Vonderhaar BK.

J Cell Physiol. 2009 Jun;219(3):659-66. doi: 10.1002/jcp.21712.

Items per page

Supplemental Content

Loading ...
Support Center